title: Regulatory issues involved in hematopoietic growth factor approval.
authors.affiliation: Division of Cytokine Biology, Food and Drug Administration, Rockville, MD 20892.
authors.forename: K C
authors.initials: KC
authors.lastname: Zoon
authors.forename: R B
authors.initials: RB
authors.lastname: Cohen
authors.forename: T
authors.initials: T
authors.lastname: Gerrard
mesh_terms: D000818:Animals; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D016298:Hematopoietic Cell Growth Factors / Q000627:therapeutic use*; D006801:Humans; D007880:Legislation, Drug; D011994:Recombinant Proteins / Q000627:therapeutic use; D014481:United States; D014486:United States Food and Drug Administration
chemical_list: D016298:Hematopoietic Cell Growth Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D016178:Granulocyte-Macrophage Colony-Stimulating Factor